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INTRODUCTION 
In 1950, J.W. Gofman (35) suggested that coronary heart disease 
(CHD) was associated with high plasma levels of certain lipoprotein density 
classes. Since then, retrospective (17, 18, 22, 27, 40) as well as prospective 
studies (12) have disclosed that several types of hyperlipoproteinemia are 
risk factors in the development of CHD (for reviews, cf. 93, 13). 
A great deal of work has been done to classify these hyperlipopro-
teinemic conditions and to elucidate their etiological mechanisms (for 
reviews, cf. 32, 56). 
Generally speaking, an increased concentration of circulating lipo­
proteins may be the result of an increased production rate, a decreased re­
moval rate, or a combination of both. The liver is the primary site of the 
synthesis and secretion of low-density lipoproteins (LDL) and very low-density 
lipoproteins (VLDL) (46). The removal of VLDL, on the other hand, is at least 
partly dependent on the activity of adipose tissue lipoprotein lipase (75). It 
is now accepted that, in patients with endogenous hyperlipoproteinemia, the 
VLDL concentration (often referred to as prebeta lipoproteins) in the plasma 
may be increased and maintained after sucrose feeding (for reviews, cf. IV). 
Most information on the effect of dietary carbohydrates on the lipid metabolism, 
however, is derived from studies in animals. Furthermore, the kinetic behavior 
of plasma and liver lipids has, in many instances, indicated marked species 
differences (2, 28, 39, 57) and many results obtained from animal studies 
cannot be extrapolated directly to man. 
Most investigations in human beings on the mechanisms of dyslipo-
proteinemic conditions have applied a kinetic approach. Thus, either isotope-
labeled glycerol or fatty acids have been administered intravenously as pre­
cursors for the endogenous hepatic lipoprotein synthesis and secretion into 
the blood, after which the decay of lipoprotein radioactivity has been followed. 
The results of these studies have been conflicting, however, partly because of 
methodological problems. This has recently been critically reviewed by Nikkilä 
et al. (55, 56). 
So far, a great deal of knowledge has been gained about the produc­
tion and removal of plasma lipids. On the other hand, only sparse information 
with respect to the metabolism of the protein part of the lipoprotein is 
available. It has been suggested that the synthesis rate of carrier proteins 
(apoproteins) may be of importance for at least the VLDL secretion rate from 
the liver (14, 32, 46, 62). 
This study was designed to obtain more direct information regarding 
the contributive role of the liver in the genesis of different dyslipoproteine-
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mie conditions in man. 
Extrahepatic cholestasis in mail is associated with well-defined 
changes in the plasma lipoprotein pattern (33, 69, 75, 76, 77, 83, 90). These 
changes are suggested to be at least partly secondary to a changed hepatic 
lipid- and protein metabolism as indicated by studies in animals (47, 73, 92) 
and in man (86). Therefore, patients with this disorder were studied and ser­
ved as models for a dyslipoproteinemic condition with a liver metabolic involve­
ment. The main purpose of this investigation, however, was to characterize and 
evaluate the role of the hepatic protein and lipid synthesis rate in the pro­
duction of increased plasma concentrations of VLDL in patients with prebeta 
hyperlipoproteinemia. 
An in vitro technique with human liver slices to determine the tri­
glyceride and phosphoglyceride synthesis capacity has previously been descri­
bed by Nilsson & Scherstên (58) from this laboratory. Another aim of this study, 
therefore, was to work out and characterize a method to measure the capacity 
of human liver slices to incorporate amino acids into proteins as an expression 
of the protein synthesis rate. 
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METHODOLOGICAL CONSIDERATIONS 
Anesthesia and liver biopsy 
The patients were premedicated one hour before the introduction of 
general anesthesia by means of diazepam and atropine. Anesthesia was given as 
hexobarbital (Evipan ), nitrous oxide, oxygen and succinyl choline. Liver 
tissue for in vitro studies was obtained by a biopsy technique according to 
Björntorp et al. (9). The technique was described in detail by Gottfries (36). 
The biopsies were performed immediately after the abdominal cavity was opened 
and the excised liver tissue was placed in ice-cold buffer solution and rapid­
ly brought to the laboratory («= 5 min.). 
Determination of the incorporation rate of leucine into proteins in human 
liver slices (I, II, III). 
Different preparations to determine the amino acid incorporation rate 
in vitro into hepatic proteins in experimental animals, e.g. subcellular sys­
tems (44, 61), suspensions of free cells (82), liver slices (20, 21, 68) and 
perfused liver (45, 53) have been described. As a very complicated sequence 
of reactions, such as the protein synthesis is studied, it is desirable to 
preserve the integrity of the liver tissue as much as possible. For obvious 
reasons, the organ preparation representing the highest degree of integrity, 
the perfused liver, could not be chosen for studies in man. Moreover, the 
tissue slice technique gives, if not quantitatively, so at least semiquantita-
tively, the same information, provided that the basic conditions with respect 
to the influence of the substrate composition and concentration are well 
characterized (68). 
Using the technique described in detail in Paper I, it was possible 
to determine, with sufficient accuracy, the incorporation rate of leucine into 
soluble proteins in human liver tissue slices. It was demonstrated that zero 
order kinetics were obtained for at least four hours when 500 mg liver slices 
were incubated in a "complete amino acid" medium. The incorporation rate of 
leucine into proteins revealed saturation kinetics at a concentration four 
times that of the serum of a complete amino acid mixture in the incubation 
medium. In this system, we found an intracellular leucine concentration of the 
same magnitude as in the medium (based on calculations of determined inulin 
space and diffusible water). According to Peters et al. (68) and Mortimore et 
al. (53), as reviewed in Paper I, the specific activity of the precursor amino 
acid in the medium may be valid for the calculation of the protein synthesis 
rate under these conditions. 
Addition of insulin to the medium (100 mU/ml) increased the incor­
poration rate of leucine by 32 % in three consecutive experiments, whereas 
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supplementation with glucose (5.5 mmol/1) or fructose (5.5 mmol/1) caused no 
change, or an inhibition, of the incorporation rate of leucine, respectively. 
These findings are in good agreement with previous studies in experimental 
animals (11, 51, 54) and indicate that the technique described is adequate to 
reveal changes in the incorporation rate of leucine into liver proteins in 
man at least as accurately as previously described for experimental animal 
liver tissue preparations. 
Leucine is metabolized in the liver to a low extent. Thus, label was 
found in CC ,^ aceto-acetate, and in lipids. This incorporation into various 
metabolites represented a small fraction, however, which agrees with other 
reports (26, 68). This finding probably reflect the relative inability of the 
liver to degrade branched-chained amino acids, which in turn makes them sui­
table as labeled precursors in in vitro studies of the present kind. 
The standard error of the method for the incorporation rate of leu­
cine into proteins, calculated on the basis of 38 duplicates, was +_ 9.5 per 
cent, and for the isolation of proteins from liver tissue _+ 4 per cent. 
Determination of the incorporation rates of glycerol and fructose into glyce-
rides, and into glycogen inhuman liver slices (II, III, IV). 
The technique used for this purpose was worked out in this labora­
tory several years ago (58). For details concerning the incubation procedure 
see Paper IV. 
The basic incubation medium consisted of 3 per cent albumin in Krebs 
Ringer phosphate buffer, pH 7.4. Palmitic acid, glycerol, and fructose were 
added to this medium to obtain the appropriate concentration of these sub­
stances in each individual experiment. As radioactive precursors for the lipid 
synthesis, glycerol-l,3-^C or fructose-U-^C were used. The incubation time 
was four hours. The incorporation time curve for glycerol and fructose into 
phospholipids and triglycerides was linear for at least five hours (58). After 
incubation, the liver slices were submerged to 10 ml chloroform-methanol (2/1, 
v/v). After 22 hours, the extract was washed with 10 ml of 0.05 M KCl by a 
modification of the method of Folch et al. (30). 
The standard error for the incorporation rate of glycerol into lipids 
was determined on the basis of a series of duplicates and was found to be 
+_ 9 per cent. 
The lipid synthesis was calculated from the specific activity of 
the precursor in the medium and recovered radioactivity in the glycerides and 
expressed as nmol incorporated glycerol or fructose per gram liver per hour. 
Analytical procedures 
Separation of different lipids in the chloroform-methanol extracts 
from plasma and liver tissue was performed by thin-layer chromatography (TLC) 
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according to Gloster & Fletcher (34). The determination of lipid phosphorus 
was performed according to the Bartlett method (5) as modified by Svennerholm 
& Vanier (89) (standard error of the method 5.0 per cent). Glyceride-glycerol 
was determined as described by Carlson (19) (error 3.3 per cent), cholesterol 
according to Sperry & Webb (85) (error 10.4 per cent), glucose according to 
Levin et al. (SO) and glycogen according to van der Vies (94) (error 4.2 per 
cent). IRI-insulin was determined radio-immunochemically according to Hales & 
Randle (41) using assay kits from Amersham (insulin immuno assay kit, the 
Radiochemical Center, Amersham, Buckingham, England) (error 7.1 per cent). Pro­
tein was quantitated according to Lowry et al. (49) (error 2 per cent). 
The radioactivity was determined in a Packard Tri-Carb (3320) liquid 
scintillation spectrometer. Correction for quenching was performed by the 
external standard method. 
Experimental procedures in patients on a carbohydrate-enriched diet (III, IV). 
All patients on a carbohydrate-enriched diet were hospitalized for 
20 days and the patient group designated as non-sucrose-fed controls for two 
days prior to the gallbladder operation. In the morning on the day after ad­
mission, after an overnight fast, capillary blood and heparinized venous blood 
samples were drawn for subsequent determination of blood glucose (50), basal 
plasma insulin (41), plasma cholesterol (85), and triglycerides (19), and for 
lipoprotein electrophoresis (71). A glucose tolerance test was performed the 
same day as described in detail in Paper IV. 
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In the morning of the second day, the intravenous fat (Intralipid ) 
tolerance test (10) was performed with the patient in the fasting state. Just 
before the tolerance test, a percutaneous biopsy of adipose tissue was taken 
from the gluteal region (66). The samples obtained were used to determine the 
lipoprotein lipase activity (67). 
The patients were given 200 g sucrose per day from the third day 
through the 17:th day. The ordinary hospital diet contained an average of 
2500 Kcal, distributed as 500 Kcal of protein, 900 Kcal of fat, and 1100 Kcal 
of carbohydrates, mainly as starch. With the aid of a dietician, approximately 
800 Kcal (160 Kcal protein, 290 Kcal fat, and 350 Kcal carbohydrates) of the 
daily food intake was replaced by 200 g of sucrose. The sucrose solution, 
kindly supplied by the Beacham Company, London, England, was flavored and dis­
pensed in 100 g bottles. 
Throughout the sucrose feeding period, blood samples were taken eve­
ry second day to determine plasma cholesterol and triglycerides. After the 
sucrose feeding period, but before the gallbladder operation, a second glucose 
tolerance test was performed on the 17:th day. The fat tolerance test, with a 
concomitant determination of the adipose tissue lipoprotein lipase activity, 
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were repeated on the 18:th day. These determinations were performed under the 
same conditions as before the sucrose feeding period. 
Statistical methods (I, II, III, IV) 
In the comparison between different groups, Student's t-test was 
used. For pair differences, Wilcoxon's test as described by Siegel (84) was 
used. Linear regressions were calculated according to the method of least 
squares. Standard procedures were also used to calculate correlation coeffi­
cients. T-tests were applied to check the significance of regression coeffi­
cients. Standard error of the methods was calculated from duplicates using the 
where d^ is the difference between duplicate measurements. The error was then 
expressed as a percentage of the mean of all determinations. 
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CLINICAL MATERIAL 
The clinical material consisted of 105 subjects, 38 men and 67 women 
aged 20-86 years. All patients except those with extrahepatic cholestasis (II) 
had a normal liver function according to the following criteria: serum biliru­
bins 1.0 mg/100 ml; thymol turbidity «=^0.10, alkaline phosphatase (EC 
3.1.3.1.), -=c. 10 units (Buch); L: aspartate : 2-oxoglutarate (EC 2.6.1.1.) 20 
units (NAD/NADiy . 
None of the patients had any known disease apart from the gallbladder 
disease and, in pertinent cases, prebeta hyperlipoproteinemia (except Patient 
No. 1, Paper III, who had slight maturity onset diabetes mellitus treated with 
sulfonylurea). At the time of the study or shortly before, none was taking any 
drug known to affect the liver function. Patients with known or suspected alco­
holic problems and women taking oral contraceptive steroids were excluded from 
the study. 
The patients were divided into different groups on the basis of their 
initial plasma lipoprotein pattern according to Fredrickson & Lees (6, 31). 
The plasma lipoprotein type was determined from repeated plasma lipid analyses, 
lipoprotein electrophoresis on agarose gel (71), and alphalipoprotein choleste­
rol determinations (6). Based on these analyses, determinations of prebeta 
lipoprotein and beta lipoprotein cholesterol were performed according to 
Gustafson et al. (40). The lipoprotein values were used for the subsequent 
lipoprotein typing. The presence, at repeated analyses, of prebeta lipopro­
teins at agarose gel electrophoresis, concomitant with ;> 35 mg/100 ml of pre­
beta lipoprotein cholesterol, were used as definition of prebeta hyperlipopro­
teinemia. The corresponding upper limit for beta lipoprotein cholesterol was 
set at 200-220 mg/100 ml, dependent on the patient's age and sex. 
The group with prebeta hyperlipoproteinemia (n = 21) comprised 6 
patients with hyperlipoproteinemia, Type II B, and 15 patients with Type IV. 
All controls were admitted to the hospital for an operation for uncomplicated 
gallbladder disease. The plasma triglyceride and cholesterol concentrations 
in the control group were not different from those of middle-aged men and wo­
men randomly selected from the same city (8). 
Fifteen of the patients studied had extrahepatic cholestasis (II). 
Clinical data on the time of the liver biopsy and the blood sampling are re­
ported in detail in Paper II. In all patients, the diagnosis was confirmed at 
laparotomy and in the five tumor patients by means of microscopy. No detec­
table metastasis in lymph nodes or liver was found in any of these patients. 
Patients Nos. 1, 3, and 11 had localized carcinoma of the head of the pancreas, 
strangulating the common bile duct, while patients Nos. 2, and 14 had small, 
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isolated bile duct carcinomas. 
Consent was obtained from all patients on the carbohydrate-enriched 
dietary regimen. No complications in connection with the liver biopsies or the 
other procedures were encountered. 
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RESULTS - EVALUATION AND DISCUSSION 
Incorporation rate of leucine into hepatic proteins in vitro in normolipopro-
teinemic controls (I). 
The incorporation rate of leucine into proteins in liver slices from 
42 normolipidemic gallstone patients was studied with the technique described 
in detail in Paper I. No sex differences were found. In subjects older than 
60 years, we found a higher (P c 0.025) incorporation rate of leucine into 
proteins than in subjects below the age of 60. Since the protein content in 
the liver tissue from these subjects was approximately the same as in the 
younger ones, this finding may be interpreted as a more rapid hepatic protein 
turnover rate in older subjects. This would be in line with the high lysosomal 
enzyme activity in aging human liver tissue (7) and is in agreement with the 
finding of an increased synthesis rate of albumin in vivo in the old rat (64). 
Provided the incorporation rate of leucine into liver proteins can 
be taken as an expression of protein synthesis, it is possible to calculate 
the synthesis rate by dividing the amount of leucine incorporated into hepatic 
proteins by the mass fraction of leucine in liver proteins 0.09 (w/w) (52). 
This will give a synthesis rate of 0.100 mg protein per hour per gram liver 
tissue, which is roughly 1/10 of the corresponding synthesis rate for rat liver 
in vitro (68). Our results might indicate a protein turnover corresponding to 
the half-life of soluble liver proteins of 35 days in man. It has to be empha­
sized, however, that the protein synthesis rate determined in vitro in rat 
liver slices has been found to be 1/5 - 1/10 of the rate determined in vivo  
(68). 
It might be questioned whether the liver tissue used in the protein 
synthesis experiments can be considered normal. Sunzel et al. (87) reported a 
higher triglyceride content (but no differences of phospholipids and choleste­
rol) in liver tissue from patients with gallstone disease than in patients 
with peptic ulcer. Nilsson & Scherstén (58), however, found no differences in 
the lipid synthesis pattern in liver slices from patients with diseases as 
different as gallstone disease, gastric disease, and renal calculus. So far, 
this seems to hold true also for the protein synthesis. This supports the 
assumption that the gallstone disease of the patients in the present study did 
not influence the results, especially not the comparison between the different 
patient groups. 
Substrate incorporation into hepatic lipids and proteins in vitro in extra-
hepatic cholestasis (II). 
In liver tissue from fifteen patients with extrahepatic cholestasis, 
we found an increased concentration (P -=r 0.025) of phosphoglycerides and pro-
teins compared with normolipidemic gallstone patients. The triglyceride con­
centration was equal while the glycogen concentration was decreased (P -=.0.05) 
in these patients. The changed lipid and protein concentrations could not be 
ascribed to a change in the hepatic water content which was equal in the two 
groups. 
The incorporation rate of glycerol into total phosphoglycerides 
(P -=0.01) as well as into the choline phosphoglycerides (P <0.05) and etha-
nol-amine phosphoglycerides (P «IJ. 0.01) was increased in cholestatic liver 
tissue compared with controls. On the other hand, liver tissue from patients 
with cholestasis incorporated glycerol into triglycerides at the same rate as 
controls. 
The incorporation rate of leucine into liver proteins was increased 
(P<r 0.0125) in the cholestatic liver tissue, which also had a high protein 
content (P«=- 0.025) compared with the controls. These findings may be inter­
preted as indicating an enhanced synthesis of phosphoglycerides and proteins 
in cholestatic liver tissue. 
This interpretation was supported by the higher concentrations of 
phosphoglycerides and proteins in the cholestatic liver slices. The final 
interpretation of these data should be made with caution, however, since the 
possibility of a changed specific activity in the immediate precursor pool 
can not be ruled out completely. The fact that the incorporation rate of gly­
cerol into triglycerides was unchanged, concomitant with a significant increase 
in the incorporation rate into phosphoglycerides, does not support the hypothe­
sis of a changed specific activity in the d -glycerophosphate pool. Moreover, 
the free leucine concentration was found to be almost equal (600-700 ^ mol/1) 
in cholestatic and normal liver tissue. 
An enhanced synthesis of phosphoglycerides in liver tissue under 
cholestatic conditions may be explained by an increased bile acid concentra­
tion in the liver. Greim et al. (38) have shown that biliary obstruction cau­
ses an increased cholic acid concentration comparatively early, whereas cheno-
deoxycholic acid increased only when the cholestasis was protracted. A stimula­
ting effect of bile acids on the lecithin synthesis seems to be well estab­
lished in different species (3, 42, 59, 79, 81, 88). The mechanism of the 
effect of bile acids on the phospholipid synthesis is not known, however. We 
have previously shown (15) that in vitro addition of bile acids to incubations 
with liver slices caused a shunting of glycerol into lecithin synthesis path­
ways. This finding provided support for the hypothesis that bile acids, in 
some way, directly affect the hepatic synthesis of lecithin. This hypothesis 
is also supported by the finding of Kennedy & Weiss (48) that the lecithin 
synthesis in rat liver preparations was stimulated in the presence of deter­
gents such as bile acids. 
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The mechanism behind the increased protein synthesis in cholestatic 
liver tissue is not easy to explain. An increased incorporation rate of amino 
acids into hepatic proteins in experimentally induced cholestasis in rats has 
been found (73). Morphometric analyses of electron micrographs of liver tissue 
from patients with cholestasis have shown an increased surface area of both 
the rough and smooth endoplasmic reticulum (37). This probably indicates a 
"hypertrophy" in that part of the cell which is mainly responsible for the 
protein synthesis. 
Our finding of a significant correlation between the incorporation 
rate of glycerol into phosphoglycerides and the incorporation rate of leucine 
into proteins in cholestatic liver may suggest a common mechanism for the en­
hancement of both these processes. In one series of experiments with control 
liver slices, however, glycocholic acid or glycochenodeoxycholic acid was 
added to the incubation medium (final concentration 0.05 mmol/1). Neither one 
of these primary bile acids influenced the incorporation rate of leucine into 
proteins in contrast to the effect of the bile acids on the incorporation rate 
of glycerol into phosphoglycerides (79). 
Another contributive mechanism to the enhanced incorporation of gly­
cerol into fatty acids and leucine into proteins in cholestatic liver tissue 
has to be considered. Thus, the reduced form of nicotin-amide-adenine nucleo­
tide monophosphate has been found to enhance the synthesis of amino acids and 
proteins (95). In a previous work, Scherstén et al. (78, 80) found that the 
ratio between reduced and oxidized nucleotides was considerably increased in 
cholestatic liver tissue. Thus, their findings are in line with those of the 
present study. 
As pointed out in the introduction, extrahepatic cholestasis can 
be looked upon as a model system for dyslipoproteinemic conditions. Whether 
the changed plasma lipoprotein pattern in cholestasis is related to the changed 
liver tissue metabolism can not be unequivocally determined on the basis of the 
present results. It appears tempting, however, to assume that the increased 
plasma lecithin concentration in this condition may be caused at least partly 
by the enhanced hepatic synthesis. An additional cause may be a diminished 
lecithin secretion into bile. The appearance of the abnormal lipoprotein-X may 
be associated with such changes in the protein and phospholipid synthesis in 
the liver. 
Effects of sucrose feeding in patients with prebeta hyperlipoproteinemia 
(HI, IV). 
Four patient groups were studied as described in detail in Papers 
III and IV. They are referred to as: non-sucrose-fed controls (n = 36), non-
sucrose-fed patients with prebeta hyperlipoproteinemia (n = 8), sucrose-fed 
controls 
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(n = IS), and sucrose-fed patients with prebeta hyperlipoproteinemia (n = 13). 
In the normolipoproteinemic patients, sucrose feeding produced an 
increase in the plasma triglycerides (P-= 0.001), a transient decrease in the 
plasma cholesterol (P --'0.005), an increase in basal insulin (P =:0.01), 
concomitant with an increased lipoprotein lipase activity (P<0.01). Only 
basal insulin increased significantly in the sucrose-fed patients with pre­
beta hyperlipoproteinemia. 
Compared with non-sucrose-fed controls, the liver triglyceride con­
tent was increased in sucrose-fed controls (P«=0.05) as well as in non-
sucrose-fed (P-= 0.05) and sucrose-fed patients with prebeta hyperlipoproteine­
mia (P c0.05). An increased incorporation rate of glycerol into hepatic tri­
glycerides was found in the above-mentioned groups except for the sucrose-fed 
patients with prebeta hyperlipoproteinemia. The higher incorporation rate of 
precursors into triglycerides was taken as an indication of an increased hepa­
tic triglyceride synthesis in the sucrose-fed controls and the non-sucrose-
fed patients with prebeta hyperlipoproteinemia. The increased liver triglyceri­
de content supports the validity of this finding. An additional fact which 
supported the finding was the significant correlation between the incorpora­
tion rate of precursors into hepatic triglycerides and the increment of plasma 
triglycerides on the seventh day of sucrose feeding in the sucrose-fed controls, 
as well as the significant correlation between the hepatic triglyceride synthe­
sis and the plasma triglyceride concentration in the non-sucrose-fed patients 
with prebeta hyperlipoproteinemia. 
In the sucrose-fed patients with prebeta hyperlipoproteinemia, the 
mean plasma triglycerides, as well as the mean incorporation rate of precur­
sors into hepatic triglycerides, showed a wide range of values. This may be an 
expression of heterogeneity within this series of biochemically typed patients 
with prebeta hyperlipoproteinemia. It should be kept in mind that this patient 
group, in addition to comprising patients with Type IV, also included 6 patients 
with Type II B. Furthermore, it remains to be shown that patients with Type IV 
hyperlipoproteinemia constitute a metabolically homogenous population (70). 
In the sucrose-fed patients with prebeta hyperlipoproteinemia, the 
mean of the incorporation rate of radioactive precursors into triglycerides 
was moderately increased but less than in the sucrose-fed controls. Caution 
should be exercised in the final interpretation of these data, however, since 
the possibility of a dilution of the label by an expanded precursor pool of 
oC -glycerophosphate can not be completely ruled out. The facts that the in­
corporation rates of glycerol and fructose into triglycerides showed an increase, 
together with a highly significant decrease in the incorporation rate into 
phosphoglycerides, however, do not support the hypothesis of a dilution of the 
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immediate precursor pool. Furthermore, these findings are in agreement with 
conclusions drawn from other investigations in man (24, 29, 70). 
The finding of a lower incorporation rate of glycerol, as well as 
of fructose, into hepatic choline phosphoglycerides in the sucrose-fed patients 
with prebeta hyperlipoproteinemia seems to be further supported by the lower 
liver content of phosphoglycerides in these patients. These data are also in 
agreement with our observation of a low choline phosphoglyceride concentration 
in the bile from the same patient group (16). The data also concur with the 
recent finding of Park et al, (65) that, in high carbohydrate-fed rats, the 
choline phosphoglyceride level in the rough microsome fraction of liver homo-
genates was significantly decreased and that the linoleic and arachidonic acids 
were virtually absent in the phospholipids of this fraction. Recently, Ailing 
et al. (1) showed that sucrose feeding rapidly caused a significant decrease 
in the proportion of linoleic acid in liver, plasma and bile choline phospho­
glycerides, indicating that sucrose feeding inhibits the cytidindiphosphate 
choline pathway (Kennedy's pathway) of the choline phosphoglyceride synthesis. 
Thus, this decreased choline phosphoglyceride synthesis seems to 
be provoked by sucrose feeding, since non-sucrose-fed patients with prebeta 
hyperlipoproteinemia had a normal incorporation rate of precursors into hepa­
tic glycerides as well as a normal hepatic phosphoglyceride content. Prebeta 
hyperlipoproteinemia is not characterized by low plasma phosphoglycerides or 
plasma choline phosphoglycerides (60), but the VLDL in Type IV have a lower 
specific density and a higher Sf value (4) and would, therefore, have a higher 
triglyceride/phosphoglyceride ratio than that of normolipoproteinemic subjects. 
The low incorporation rates of glycerol and fructose into phospho­
glycerides are most likely not an effect of the conditions chosen for the in 
vitro incubation. Neither an increase in the fatty acid amount in the system 
(58, 63) nor the use of another fatty acid substrate like oleic acid (43) or 
linoleic acid (15) would be expected to increase the incorporation into phos­
phoglycerides. The addition of insulin to the system would be expected to 
influence the incorporation into phosphoglycerides only to a moderate extent 
(91). 
The incorporation rate of leucine into hepatic proteins was equal 
in non-sucrose-fed controls (n = 20) and non-sucrose-fed patients with pre­
beta hyperlipoproteinemia (n = 9). Three of the sucrose-fed controls (n = 4) 
incorporated leucine into proteins at a rate above the 95 per cent confidence 
level of that for non-sucrose-fed controls. This may indicate an insulin effect 
on the hepatic protein synthesis capacity (I, 51), which has been found also 
after long-term glucose feeding in rats (23). No change in the incorporation 
rate of leucine into hepatic proteins in sucrose-fed patients with prebeta 
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hyperlipoproteinemia was found in the present investigation. In spite of the 
limited number of subjects studied, the question must be raised if this diffe­
rence was founded on a changed insulin sensitivity or on a different response 
in the liver of the sucrose-fed patients with hyperlipoproteinemia. It appears 
to be well established that plasma insulin stimulates the adipose tissue lipo­
protein lipase activity and in this way facilitates the removal of VLDL. Both 
in controls and in patients with prebeta hyperlipoproteinemia, sucrose feeding 
caused an increase in the basal insulin level, but the adipose tissue lipopro­
tein lipase increased only in controls. This finding may support the hypothe­
sis of a changed sensitivity or response to insulin in prebeta hyperlipopro­
teinemia. 
So far, the findings in the present study agree with the reports of 
Reaven et al. (72) and Nikkilä & Kekki (55) that the triglyceride turnover is 
above normal in patients with endogenous hyperlipoproteinemia. Based on their 
own observations, Nikkilä & Kekki (55) suggested that the primary defect in 
most cases of Type IV endogenous hyperlipoproteinemia is an increased inflow 
transport of plasma triglycerides. Sucrose-fed patients with prebeta hyperlipo-
proteinemia showed a decreased fractional elimination rate (P -=i0.05) of exo­
genous fat without changes in lipoprotein lipase activity, also indicating an 
insufficient removal capacity for plasma triglycerides. In the sucrose-fed 
controls, on the other hand, we found a significantly increased lipoprotein 
lipase activity together with a change from an increase toward normal initial 
plasma triglyceride levels which indicated an'adequately clearing function of 
VLDL. Thus, an increased transfer of triglycerides from the liver into plasma 
causes a greater concentration increase in subjects with inherently "weak" 
removal systems. Obviously, there are indications of an increased production, 
as well as of a defect removal, of plasma VLDL in patients with prebeta hyper­
lipoproteinemia. 
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SUMMARY 
1. Liver tissue from normolipidemic gallstone patients older than 60 years 
incorporated leucine into hepatic proteins at a higher rate than liver 
tissue from younger individuals, indicating a higher protein turnover 
rate in the older patients. 
2. Cholestatic liver tissue contained more proteins and phosphoglycerides, 
and incorporated precursors into proteins and phosphoglycerides at a 
higher rate than presumably normal liver tissue. The incorporation rate 
of glycerol into hepatic phosphoglycerides correlated significantly with 
the plasma phosphoglyceride concentration. 
3. Liver tissue from patients with prebeta hyperlipoproteinemia on an ordi­
nary diet contained more triglycerides and incorporated glycerol into 
triglycerides at a higher rate than liver tissue from normolipidemic gall­
stone patients. The incorporation rate of precursors into hepatic trigly­
cerides correlated significantly with the plasma triglyceride concentra­
tion, indicating an increased hepatic triglyceride synthesis rate. 
4. After sucrose feeding for 14 days, liver tissue from patients with pre­
beta hyperlipoproteinemia had a lower content of phosphoglycerides and 
incorporated precursors into phosphoglycerides at a lower rate compared 
with non-sucrose-fed patients with prebeta hyperlipoproteinemia, indica­
ting a phosphoglyceride synthesis defect provoked by the sucrose feeding. 
5. Sucrose-fed controls showed an increased incorporation rate of glycerol 
and fructose into hepatic triglycerides in vitro, which correlated with 
the increase in the plasma triglyceride concentration indicating an in­
creased triglyceride synthesis rate. 
6. The fractional elimination rate of exogenous fat decreased after sucrose 
feeding in controls as well as in patients with prebeta hyperlipoproteine­
mia, indicating a removal defect for at least exogenous fat. 
7. The adipose tissue lipoprotein lipase activity was increased after sucrose 
feeding in controls and was inversely correlated to the plasma triglyce­
ride concentration in controls as well as in patients with prebeta hyper­
lipoproteinemia. 
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